Industri

AviadoBio broadens vMiX gene silencing licence with Kin...

The agreement broadens AviadoBio’s existing rights, which were previously limite...

From fintech to aesthetic injectables: Lessons in navig...

Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarificati...

Karnataka holds 64th Vision Group on Biotechnology meet...

Meeting discusses biotechnology strategy, AI integration, biomanufacturing and f...

Glenmark launches Methylene Blue Injection USP in US

Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL

David Zambrana Elevated to President and CEO of Jackson...

On June 1, David Zambrana officially assumed the role of President and Chief Exe...

Chris Jann of Wold on Trends, Technology and the Evolut...

In April Wold Architects & Engineers announced Chris Jann as a Healthcare Busine...

ALK’s EURneffy secures MHRA approval for anaphylaxis tr...

This approval is said to be the first in the UK for a needle-free adrenaline tre...

Alkermes’ alixorexton secures FDA and EC orphan designa...

The FDA granted the status to alixorexton for idiopathic hypersomnia while the E...

ILAMED expands international presence with centres in K...

Institute to launch Cairo centre in September 2026 as part of its overseas exp...

Security System

SentriZone® by Crotega is a facility-based security system designed to help orga...

ChristianaCare Opens Neighborhood Hospital in Aston, Pa.

ChristianaCare opened the $50.9 million ChristianaCare Hospital, Aston, in early...

Ensera and Argonaut partner to streamline supply for dr...

Delivering an integrated fill-finish and device assembly and packing collaborati...

Simcere and Stanford partner to develop IPF therapies

Under the deal, Simcere will provide funding for exploratory research on a first...

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC ...

This approval covers patients with ccRCC who are at intermediate-high or high ri...

Novartis India launches Pluvicto for PSMA-positive meta...

Radioligand therapy approved for eligible patients with PSMA-positive prostate ...

Ipca Laboratories and Bhami’s Research Laboratory signs...

Agreement enables development and commercialisation of monoclonal antibody prod...